Trial · NCT00248170
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Disease Free Survival | Letrozole | NA | 95% Confidence Interval 84.14 to NA | Months | |
| Disease Free Survival | Anastrozole | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival | Letrozole | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival | Anastrozole | NA | 95% Confidence Interval NA to NA | Months | |
| Time to Development of Distant Metastases | Letrozole | NA | 95% Confidence Interval 84.14 to NA | Months | |
| Time to Development of Distant Metastases | Anastrozole | NA | 95% Confidence Interval NA to NA | Months | |
| Time to Development of Contra Lateral Breast Cancer | Letrozole | NA | 95% Confidence Interval NA to NA | Months | |
| Time to Development of Contra Lateral Breast Cancer | Anastrozole | NA | 95% Confidence Interval NA to NA | Months | |
| Distant Disease-free Survival | Letrozole | NA | 95% Confidence Interval 84.14 to NA | Months | |
| Distant Disease-free Survival | Anastrozole | NA | 95% Confidence Interval NA to NA | Months | |
| Change From Baseline in Serum Lipid Profiles | Letrozole | 6 months | 5.643 | 95% Confidence Interval 5.584 to 5.701 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Anastrozole | 6 months | 5.553 | 95% Confidence Interval 5.495 to 5.611 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Letrozole | 12 months | 5.569 | 95% Confidence Interval 5.510 to 5.629 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Anastrozole | 12 months | 5.511 | 95% Confidence Interval 5.452 to 5.570 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Letrozole | 24 months | 5.508 | 95% Confidence Interval 5.445 to 5.572 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Anastrozole | 24 months | 5.436 | 95% Confidence Interval 5.373 to 5.499 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Letrozole | 36 months | 5.429 | 95% Confidence Interval 5.359 to 5.500 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Anastrozole | 36 months | 5.427 | 95% Confidence Interval 5.357 to 5.497 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Letrozole | 48 months | 5.395 | 95% Confidence Interval 5.323 to 5.468 | mg/dL |
| Change From Baseline in Serum Lipid Profiles | Anastrozole | 48 months | 5.366 | 95% Confidence Interval 5.293 to 5.438 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00248170/results